In fiscal year 2021, Polaris AI Pharma (041910) reported revenue of 60.4 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2021 | 60.4 billion KRW | 4.2 billion KRW | 6.9 billion KRW | [source] |
| 2020 | 61.3 billion KRW | 8.0 billion KRW | 15.7 billion KRW | — |
| 2019 | 46.5 billion KRW | 3.8 billion KRW | 15.2 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2021 | 131.8 billion KRW | 10.5 billion KRW | 121.3 billion KRW | [source] |
| 2020 | — | — | — | — |
| 2019 | — | — | — | — |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2021 | 603 million KRW | 5.7 billion KRW | -1.4 billion KRW | [source] |
| 2020 | — | — | — | — |
| 2019 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.
Cash flow figures for the relevant year were not collected.